(version november 2018) · sop tb tier.net tmc tpt top qi qip ultf vl wac wbot wphcot 10/10...
TRANSCRIPT
![Page 1: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/1.jpg)
(version November 2018)
![Page 2: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/2.jpg)
HIV and TB Supportive Supervision Toolkit (v. November 2018)
Contributors:
Jackie Smith Mildred Shabangu
Sibongile Shezi Neziswa Mdaka Stiaan Byleveld Joslyn Walker
Patricia Bartman
Editing and proofreading:
Judith King Ross Haynes
Design and layout:
Lebo Dikobe
Suggested citation:
Health Systems Trust. HIV and TB Supportive Supervision Toolkit. Durban: Health Systems Trust; 2018.
![Page 3: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/3.jpg)
Purpose of the Toolkit; how to use this Toolkit
List of acronyms and abbreviations
Section A: Introduction
SA SURE Plus Project Approach
South Africa's health policy implementation architecture
Section B: Prevention
Options for notifying your partner about HIV testing
Steps for Index Case Contacts Testing Services
Index case contacts tracing:
Partner Information Form (in two parts)Contact Referral Slip (CDC-designed)
Partner Contact Form (other)
Outcome of Partner Testing Services FormTesting Outcome Form for HIV-exposed children
Four streams of care diagram: Ideal Clinic re-organisation of services
Process ow for IPT monitoringIPT audit tool
Process ow for community testing co-ordination
Section C: Care and treatment
Process for Provider-initiated Testing and Counselling (PITC)
PITC facility owFacility Baseline Assessment
Standard operating procedure for review of registers
Laboratory processes
Facility Improvement Plan (FIP) development processFacility Planning Cycle
Bottleneck Analysis diagram
Facility Technical Working Group (FTWG) stakeholders
Process ows for unique ID and linkage monitoring
Viral load management process
Viral load monitoring at 6 months Quality Improvement Plan (QIP) 'KwikSkwiz'
90-90-90 Strategy:
A-1
A-2
A-4
A-5
B-1
B-2Index Client Information Form B-3
Partner Elicitation Form B-4
B-7B-8
B-9
B-10
B-11Four streams facility algorithm B-12
Single facility sketch plan B-13Multi-building facility sketch plan B-14
TPT diagram B-15
B-16B-17
B-18
C-1C-2C-3
C-4
C-6C-6C-7
C-8
C-9
C-10C-11
C-12
C-5
B-5
![Page 4: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/4.jpg)
Adherence Club data owLinkage Ofcer role and standard operating procedure
Community outreach relationshipsCommunity / Differentiated Care Model:
C-13C-14C-15
Supervision of Data CapturersData management:
C-16
![Page 5: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/5.jpg)
Purpose of the HIV and TB Programme Toolkit:
This Toolkit has been compiled to support health managers and partners in providing on-site, supportive supervision to facility staff by standardising and focusing supervision practices, thereby increasing efciencies in the priority programmes.
The processes and algorithms contained in the Toolkit are derived from National Department of Health policies and guidelines, which should always be utilised as key source documents for deeper understanding and guidance.
This Toolkit enables any manager or supervisor to examine processes in the clinic to determine whether they are working well – and if not, to identify where the challenges lie and design Quality Improvement Plans.
This is not an exhaustive set of tools, and it will be expanded periodically on request to the project management.
How to use this Toolkit
The Toolkit has been organised into three thematic sections: Introduction; Prevention; Care and Treatment.
A good place to start is to review all the Toolkit content when you receive it. If you are familiar with the material, it will be easier during a busy day to refer quickly to a specic tool for supervision purposes. Check the Table of Content to identify items that would be especially useful to you.
As you review the contents, make notes of the particular challenges experienced in your facility with systems and processes. If you need something that is not available in the Toolkit, suggest this to HST so that a relevant tool can be developed and added to the material.
Use the Toolkit material to help organise your thoughts, map out the supervision tasks you wish to accomplish, and set timelines.
Managing supervision practice requires creativity as well as a set of learnt skills. Discussing supervision issues with your peers in the eld is a good way to gather further information and ideas.
To download a PDF of this Toolkit, go to: http://www.hst.org.za/publications/HST%20Publications/HIV%20and%20TB%20Supportive%20Supervision%20Toolkit.pdf
HIV and TB Supportive Supervision Toolkit (version November 2018) Section A - page 1 of 5
![Page 6: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/6.jpg)
List of acronyms and abbreviations
ACR
ANC
ART
BNA
CBO
CCMDD
CDC
CEO
COP
CRAG
DATIM
DatCap
DCST
DHP
DIMES
DIP
DME
DoB
DOP
DREAMS
DsD
DQA
eGFR
EMR
FIP
FOP
FTWG
HIV
HST
HTC
HTS
HPRS
ICRM
ICSM
ID
IPT
IPV
LAC
LO
LTFU
MC
HIV and TB Supportive Supervision Toolkit (version November 2018) Section A - page 2 of 5
ART clinical record
antenatal care
antiretroviral therapy
Bottleneck Analysis
community-based organisation
Central Chronic Medicine Dispensing and Distribution
Centers for Disease Control and Prevention
Chief Executive Ofcer
Country Operational Plan
serum cryptococcal antigen
Data for Accountability, Transparency and Impact
Data Capturer
District Clinical Specialist Team
District Health Plan
DREAMS Integrated Monitoring and Evaluation System
District Implementation Plan
District Monitoring and Evaluation Ofcer
date of birth
District Operational Plan
Determined, Resilient, Empowered, AIDS-free,
Mentored, and Safe [PEPFAR empowerment programme for
adolescent girls and young women]
direct service delivery
data quality assessment
estimated glomerular ltration rate [a blood test to measure kidney function]
emergency medical record
Facility Implementation Plan
Facility Operational Plan
Facility Technical Working Group
Human Immunodeciency Virus
Health Systems Trust
HIV testing and counselling
HIV Testing Services
Health Patient Registration System
Ideal Clinic Realisation and Maintenance
Integrated Clinical Services Management
identication
isoniazid preventive therapy
intimate partner violence
Local AIDS Council
Linkage Ofcer
lost to follow-up
maternal and child
![Page 7: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/7.jpg)
List of acronyms and abbreviations
HIV and TB Supportive Supervision Toolkit (version November 2018) Section A - page 3 of 5
MCWH
M&E
MDR
MMC
Mx
N/A
NC
NCD
NCS
NHLS
OM
OSS
OVC
PHC
PITC
PLHIV
PMTCT
PN
PT
Rx
SA SURE Plus
SCM
SRH
SOP
TB
TIER.Net
TMC
TPT
ToP
QI
QIP
uLTF
VL
WAC
WBOT
WPHCOT
10/10
maternal, child and women's health
monitoring and evaluation
multidrug-resistant
medical male circumcision
medicine
not applicable
Nurse Clinician
non-communicable disease
National Core Standards
National Health Laboratory Service
Operational Manager
Operation Sukuma Sakhe
orphans and vulnerable children
primary health care
provider-initiated testing and counselling
people living with HIV
prevention of mother-to-child transmission of HIV
Professional Nurse
Prociency Testing
a doctor's prescription ['recipe']
South Africa's Sustainable Response to HIV and TB Project
supply chain management
sexual and reproductive health
standard operating procedure
tuberculosis
Three Interlinked Electronic Register for TB and HIV
traditional male circumcision
TB preventive therapy [A course of isoniazid (INH) given for a period
of 12 months to HIV-positive patients who do not have active TB
to minimise the risk of them contracting it]
termination of pregnancy
quality improvement
Quality Improvement Plan
unconrmed loss to follow-up [TIER.Net abbreviation]
viral load
Ward AIDS Committee
Ward-based Outreach Team
Ward-based Primary Health Care Outreach Team
A CDC process-strengthening term, relating to a focus on 10
high-burden facilities in 10 high-burden districts, categorised
into four key activity areas; this term is likely to change but is
currently in use and is referred to in the Toolkit.
![Page 8: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/8.jpg)
SA SURE Plus Project – Approach
Health Systems Trust (HST), through the SA SURE Plus Project, is the CDC-funded District Support Partner in four districts in South Africa's KwaZulu-Natal Province. Since district-level health facilities and community health services form the foundation of health service delivery, effective implementation of the country's health policies and strategies is dependent on well-functioning health facilities.
As illustrated in the accompanying diagram, the project's approach to supporting district health facilities covers a wide range of activities. To improve the quality of health care, SA SURE Plus focuses mainly on health systems strengthening in the areas of Ideal Clinic Realisation and Maintenance (ICRM), change management within the UNAIDS 90-90-90 initiative, expanding the roll-out of alternative access to chronic medication through the Central Chronic Medicine Dispensing and Distribution (CCMDD) programme, and the strategic placement of supplemental staff to assist facilities with HIV and TB services and data management. The community-based services include mobile outreach services, as well as the facilitation of support groups for newly diagnosed and unstable patients and adherence clubs for stable patients.
This work is aligned with the aims of and guidelines for Primary Health Care Re-Engineering, National Health Insurance, and the National Core Standards for Health Establishments in South Africa.
HIV and TB Supportive Supervision Toolkit (version November 2018) Section A - page 4 of 5
SA SURE Plus
![Page 9: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/9.jpg)
Co
mm
un
ity s
erv
ices
Facilit
y-b
ased
serv
ices
Nati
on
al str
ate
gie
s
Sch
ool
He
alth
WB
PH
CO
Ts
PH
CR
e-
en
gin
ee
rin
g
Na
tiona
l
He
alth
Insu
ran
ce
TB
/HIV
in
tegra
tion
DC
ST
90
-90-9
0
Na
tio
na
l S
tra
teg
ic
Pla
n
Na
tiona
l A
dhe
ren
ce
Str
ate
gy
Dis
tric
t-b
ased
serv
ices
ICS
M
Na
tiona
l Co
re
Sta
nd
ard
s
Su
pp
ort
g
rou
ps
CC
MD
D
Ad
he
rence
cl
ub
s
Sp
ace
d
Fa
st-la
ne
ap
poin
tme
nts
Ide
al
Clin
ic
EM
R
HP
RS
Dis
tric
t H
ea
lth
Pla
n
DIP
De
ca
ntin
g
pla
n
Pro
vin
cia
l o
vers
igh
t
EM
R
Co
mm
un
ity
FO
P
So
uth
Afr
ica’s
healt
h p
olicy i
mp
lem
en
tati
on
arc
hit
ectu
re
HIV and TB Supportive Supervision Toolkit (version November 2018) Section A - page 5 of 5
![Page 10: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/10.jpg)
![Page 11: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/11.jpg)
Dete
rmin
e the p
refe
rred
meth
od o
f part
ner
noti
catio
n o
r ch
ild test
ing for
each
nam
ed
part
ner/
child
and
reco
rd o
n P
art
ner
Info
rmati
on
Fo
rmB
iolo
gic
al C
hild
ren
In
form
ati
on
a
nd/o
r F
orm
Ste
p 4
Intr
oduce
index
case
conta
cts
test
ing s
erv
ices
to th
e in
dex
clie
nt d
uring p
re-t
est
sess
ion o
r PM
TC
T/A
RT
vis
it
Ste
p 1
Obta
in a
list
of s
exu
al a
nd
needle
-sharing p
art
ners
and b
iolo
gic
al c
hild
ren <
15 w
ith u
nkn
ow
n
HIV
sta
tus
Ste
p 2
Scr
een a
ll nam
ed p
art
ners
for i
ntim
ate
part
ner vi
ole
nce
(IP
V)
Ste
p 3
Conta
ct a
ll nam
ed p
art
ners
and test
all
bio
logic
al
child
ren <
15 w
ith u
nkn
ow
n s
tatu
s usi
ng the
pre
ferr
ed a
ppro
ach
Ste
p 5
Reco
rd p
art
ner
noti
catio
n a
nd fam
ily test
ing
outc
om
es
on the O
utc
om
e o
f P
art
ner
/Ch
ild
ren
Testi
ng
Fo
rm
Ste
p 6
Pro
vide a
ppro
priate
serv
ices
for
child
ren b
ase
d
on H
IV s
tatu
s, s
ero
conco
rdant/dis
cord
ant
part
ners
, or
work
to s
upport
dis
closu
re
Ste
p 7
Use
the
to
P
art
ner/
Ch
ild
ren
In
form
ati
on
Fo
rms
docu
ment
resu
lts o
f IP
V s
creenin
g a
nd
pre
ferr
ed
pa
rtn
er
noti
catio
n a
nd/o
r ch
ild te
stin
g m
eth
od
.
Com
ple
te o
ne f
orm
for
each
na
me
d p
art
ne
r
Use
the
to
In
dex C
ase C
on
tacts
Te
sti
ng
Ta
lkin
g P
oin
ts
intr
oduce
part
ner/
fam
ily t
est
ing to
th
e in
de
x cl
ien
t a
nd
co
mple
te t
he I
nd
ex C
lien
t In
form
ati
on
Fo
rm
Use
the
to
P
art
ner/
Ch
ild
ren
* E
lic
ita
tio
nF
orm
sre
cord
part
ner(
s)’/c
hild
(ren)’s
na
me
s a
nd
co
nta
ct
info
rmatio
n
Exc
lud
e p
art
ne
rs p
osi
ng
a h
igh
ris
k o
f IP
V;
refe
r in
de
x cl
ien
t to
IP
V/O
VC
se
rvic
es
wh
ere
ava
ilab
le a
nd
dis
cuss
oth
er
op
tion
s fo
r d
iscl
osu
re.
Cli
en
t re
ferr
al:
Coach
clie
nt
on
dis
closu
re;
Pro
vide ‘T
ips
for
telli
ng y
our
part
ner
about
HIV
’ and R
efe
rral S
lipF
acil
ity-b
ased
: C
onr
m a
n
appoin
tment
to t
est
bio
logic
al
child
ren <
15
Co
ntr
act
refe
rral:
Pro
vide
refe
rral c
ard
and d
iscl
osu
re
script;
agre
e t
hat
the c
lient
will
re
fer
the p
art
ner
or
bring t
he
child
for
HT
S w
ithin
seve
n d
ays
.
Pro
vid
er
refe
rra
l: In
itia
te
pa
rtn
er
con
tact
atte
mp
ts u
sin
g
tele
ph
on
e a
nd
ho
me
vis
it
sc
rip
ts
Co
mm
un
ity
-ba
se
d:
Co
nr
m a
d
ay/
time
fo
r th
e p
rovi
de
r to
te
st
the
ch
ild(r
en
) in
th
e h
om
e.
Du
al re
ferr
al:
Co
ach
th
e c
lien
t o
n jo
int d
iscl
osu
re; m
ake
a p
lan
fo
r w
he
n a
nd
wh
ere
join
t d
iscl
osu
re w
ill ta
ke p
lace
; o
ffe
r H
TS
to
pa
rtn
er
Wa
s th
e p
art
ne
r su
cce
ssfu
lly
con
tact
ed
?W
as
the
ch
ild te
ste
d?
Reco
rd s
ucc
ess
ful p
art
ner
conta
ct o
r ch
ild t
est
(incl
udin
g H
IV s
tatu
s) o
n t
he
Ou
tco
me o
f P
art
ner/
Ch
ild
ren
Testi
ng
Fo
rm
If
, in
itia
te p
rovi
de
r re
ferr
al f
or
co
ntr
ac
t re
ferr
al
pa
rtn
ers
or
ho
me
te
stin
g fo
r ch
ildre
n a
fte
r se
ven
d
ays
; o
the
rwis
e r
eco
rd u
nsu
cce
ssfu
l co
nta
ct o
n
the
Ou
tco
me
of
Pa
rtn
er/
Ch
ild
ren
Te
sti
ng
Fo
rm
Ste
ps f
or
ind
ex c
ase c
on
tacts
testi
ng
serv
ices
*Note
: N
o B
iolo
gic
al C
hild
Elic
itation
F
orm
is a
vaila
ble
as
yet.
Yes
No
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 1 of 18
![Page 12: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/12.jpg)
Op
tio
ns f
or
no
tify
ing
yo
ur
part
ner
ab
ou
t H
IV t
esti
ng
Cli
en
t re
ferr
al =
Tell
your
part
ner
about yo
ur
HIV
sta
tus
an
d e
nco
ura
ge
him
or
her to
com
e to
the h
ealth
faci
lity
for a
n H
IV te
st.
Pro
vid
er
refe
rral =
A c
ounse
llor or oth
er h
ea
lthca
re p
rovi
de
r w
ill c
all
or vi
sit y
ou
r part
ner and in
form
them
that t
hey
need to
test
for H
IV.
Co
ntr
act
refe
rral
= Y
ou a
nd t
he c
ounse
llor
will
wo
rk t
og
eth
er
to n
otif
y yo
ur
part
ner.
You w
ill h
ave
seve
n d
ays
to tell
you
r p
art
ne
r, a
fte
r w
hic
h th
e c
ou
nse
llor
will
conta
ct y
our part
ner.
Du
al
refe
rral
= T
he c
ounse
llor/
pro
vider
will
sit
with
yo
u a
nd
yo
ur
pa
rtn
er
an
d
support
you a
s yo
u te
ll yo
ur part
ner about y
ou
r H
IV s
tatu
s.
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 2 of 18
![Page 13: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/13.jpg)
Instructions: Complete this form while interviewing the HIV-positive index clientwho has verbally agreed to receive index partner testing services.
Transgender (male to female) Transgender (male to female)Gender: Male: Female
Date form completed (dd/mm/yyyy):
Name of person completing form:
Name of health facility or HIV testing site:
INFORMATION ABOUT THE INDEX CLIENT
Index client's name (Last, First, Middle):
DoB (dd/mm/yyyy): Age: years
Marital status: Single Engaged to be married Married/cohabitating�monogamous
Divorced Widow/er Married�polygamous: #wives
*Complete one form per index client
Client's personal cell-phone number:
Alternative contact number (if available):
Address (including any landmarks, e.g. next to the church):
Date of HIV diagnosis: (dd/mm/yyyy):
Is the index client currently enrolled in an HIV treatment programme?
If yes, name of health facility:
If yes, list the index client's ART enrolment number:
For women: How many children younger than 15 years does the index client have?
How many of these children should be tested for HIV?
Index Client Information Form
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 3 of 18
![Page 14: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/14.jpg)
Instr
ucti
on
s: A
sk the in
dex
clie
nt to
tell
you the n
am
es
of all
the p
eople
they
have
had s
ex
with
in the p
ast
12 m
onth
s,
incl
udin
g b
oth
main
/marr
ied p
art
ners
and c
asu
al/u
nm
arr
ied p
art
ners
. If the c
lient
inje
cts
dru
gs,
ask
them
to a
lso tell
you the
nam
es
of th
eir in
ject
ing d
rug u
se p
art
ners
. Y
ou m
ay
wis
h to s
tart
with
the m
ain
se
x part
ner
and then a
sk a
bout oth
er
part
ners
, or
you m
ay
wis
h to s
tart
by
ask
ing a
bout th
e m
ost
rece
nt part
ner
and w
ork
ing b
ack
ward
s in
tim
e.
Ph
on
e n
um
ber
Alt
ern
ati
ve p
ho
ne
nu
mb
er
1)
2)
3)
4)
5)
6)
7)
8)
9)
10)
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Unkn
ow
n
Lis
t n
am
es(s
) o
f p
art
ners
(Tic
kif
nam
e is
unkn
ow
n)
Co
mp
lete
on
e f
orm
fo
r each
in
dex c
lien
t
Part
ner
Elicit
ati
on
Fo
rm
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 4 of 18
![Page 15: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/15.jpg)
Instructions: Ask the client to give you as much information as they can about each of the partners they named on the partner elicitation form. Write 'N/A' for any information that is not available. After completing a separate form for each contact, le all completed forms in the client's folder or medical chart.
Partner's DoB (dd/mm/yyyy):
Partner's name (Last, First, Middle):
Partner's nickname:
Partner's gender:
Partner's physical description:
Partner's age: years
Male Transgender Female
How would you describe your relationship to this partner?
My wife/husband/ancé/ancée We live together but are not married My girlfriend/boyfriend Someone I had sex with for fun Someone who pays me or gives me things to have sex with her/him Someone I paid to have sex with
Yes No Don’t Know Declines to answer
Yes No Don’t Know Declines to answer
Yes No Declines to answer
If known HIV-positive partner: Is this partner currently taking medications for HIV?
As far as you know, has this partner ever tested positive for HIV?
Do you currently live with this partner?
*Complete one form (two pages) for each partner named by the index client.
Partner Information Form (page 1)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 5 of 18
![Page 16: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/16.jpg)
Partner Information Form (page )2
1. Has [partner's name] ever hit, kicked, slapped, or otherwise physically hurt you?
2 . Has [partner's name] ever threatened to hurt you?
2 . Has [partner's name] ever forced you to do something sexually that made you feel uncomfortable?
Yes No
Yes No
Yes No
Instructions: Show the 'Options for Getting Your Partner Tested' card to the index client and review the four options.
Ask the client which option they would prefer and record their chosen option below.
If the client choses 'Contract referral', record the date (7 days from today's date) by which the partner should come for HIV testing services.
Contract Referral: Both the index client and healthcare provider will notify the partner. The index client will rst try to notify the partner no later than [date] _____/_____/_______, after which the provider will contact the partner (with permission from the index client).
Dual Referral: The index client and healthcare provider will jointly notify the partner. This joint session will occur on _____/_____/________
Index client's plan for notifying this partner:
Client Referral: Index client will notify the partner
Provider Referral: Healthcare providers will notify the partner
No partner testing is needed; the partner is known to be HIV-positive.
Partner testing is not recommended at this time due to safety concerns.
Because your safety is very important to us, we ask all clients the following questions:
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 6 of 18
![Page 17: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/17.jpg)
HIV is very common in our community. It is important that you come for an HIV test at [name of health facility] _________________________________________ so that you can learn your HIV status. If you are HIV-negative, we can give you information on how you can remain free from HIV. If you are HIV-positive, we can give you medicines to treat your HIV. These medicines will help you live a long life and reduce your chance of passing HIV onto others.
HIV testing services are available from Monday to Friday from 8:30 in the morning until 5:00 in the evening. We hope you will come for an HIV test at your earliest convenience.
HIV is very common in our community. It is important that you come for an HIV test at [name of health facility] _________________________________________ so that you can learn your HIV status. If you are HIV-negative, we can give you information on how you can remain free from HIV. If you are HIV-positive, we can give you medicines to treat your HIV. These medicines will help you live a long life and reduce your chance of passing HIV onto others.
HIV testing services are available from Monday to Friday from 8:30 in the morning until 5:00 in the evening. We hope you will come for an HIV test at your earliest convenience.
Please bring this referral slip with you.
Signature of healthcare provider:
Date:
Please bring this referral slip with you.
Signature of healthcare provider:
Date:
REFERRAL SLIP
REFERRAL SLIP
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 7 of 18
![Page 18: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/18.jpg)
Client name:
ID number:
Alternative contact number (if available):
Date of visit: Form completed by:
File number
Personal cell number:
Name:
Partner invitation letter given:
Male Female
Diagnoses: HIV TB HIV&TB
(If 'No', reason:
PART A: To be completed by counsellor for all clients testing positive at their clinic visit or during outreach:
Contact code Contact cell number: Contact tested at booking
Full physical address:
Would like home-based HIV testing for partner: Yes No (If 'Yes', complete the rest of this form.)
I hereby confirm that the details are correct and that I agree to have a community health worker call me to schedule a home visit to offer HIV counselling and testing services to my partner.
The best time to call me is:
Client's signature:
Staff member's name:
Agreed time and date:
Date:
Staff signature:
Protection of confidentiality
Yes No
PART B: To be completed by the health worker doing home testing
No (If 'No', reason):
Diagnoses: HIV-neg TB-neg HIV-pos HIV&TB TB-pos
Testing done:
Number of other people/contacts tested:
Initiated same day on: ART TB IPT Referred to
Yes
Date of referral/appointment: Facility staff name: Number:
Clinic for initiation (if 'Yes')
PART C: To be completed by NC/PN initiating Rx
Date partner/contact initiated on Rx:
Initiated by:
Signature:
PART D: To be completed by Data Capturer
File number:
Date file captured on TIER.Net:
File captured by:
Signature:
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 8 of 18
![Page 19: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/19.jpg)
IND
EX
CL
IEN
T IN
FO
RM
AT
ION
Nam
e:
HT
S/A
RT
Clin
ic N
um
ber:
Gen
der:
□
Male
□ F
em
ale
□ T
ransg
ender
Date
of
bir
th:
/ /
*Co
mp
lete
ad
dit
ion
al fo
rms if
ind
ex c
lien
t h
as m
ore
th
an
TH
RE
E p
art
ners
.
G
en
der:
□ M
ale
□ F
em
ale
□
Tra
nsg
ender
Date
of
bir
th:
Typ
e o
f p
art
ner
testi
ng
: □
Clie
nt □
Pro
vider
□ C
ontr
act, d
ate
_
D
ate
/Meth
od
of
1s
t co
nta
ct
att
em
pt:
/ /
P
hone
Hom
e
Date
/Meth
od
of
2n
d c
on
tact
att
em
pt:
/ /
P
hone
Hom
e
Date
/Meth
od
of
3rd
co
nta
ct
att
em
pt:
/ /
P
hone
Hom
e
Was
part
ner
co
nta
cte
d?
□
Yes □
N
o
If y
es, w
ho
co
nta
cte
d p
art
ner?
□
Clie
nt □
Pro
vider
□ C
lient +
Pro
vider
Ou
tco
me o
f P
art
ne
r Testi
ng
Serv
ices:
□ P
art
ner
rece
ived a
n H
IV test
□
Part
ner
refu
sed a
n H
IV test
□
Part
ner
know
n to b
e H
IV-p
osi
tive
□ O
ther:
Part
ner’
s H
IV s
tatu
s (
if t
este
d):
□
HIV
-posi
tive
□ H
IV-n
egativ
e
Is t
he p
art
ner
on
AR
T (
if H
IV-p
osit
ive)?
□
Yes
□
No
/ /
PA
RT
NE
R 1
G
en
der:
□ M
ale
□ F
em
ale
□
Tra
nsg
ender
Date
of
bir
th:
Typ
e o
f p
art
ner
testi
ng
: □
Clie
nt □
Pro
vider
□ C
ontr
act, d
ate
_
D
ate
/Meth
od
of
1s
t co
nta
ct
att
em
pt:
/ /
P
hone
Hom
e
Date
/Meth
od
of
2n
d c
on
tact
att
em
pt:
/ /
P
hone
Hom
e
Date
/Meth
od
of
3rd
co
nta
ct
att
em
pt:
/ /
P
hone
Hom
e
Was
part
ner
co
nta
cte
d?
□
Yes
□
No
If y
es, w
ho
co
nta
cte
d p
art
ner?
□
Clie
nt □
Pro
vider
□ C
lient +
Pro
vider
Ou
tco
me o
f P
art
ne
r Testi
ng
Serv
ices:
□ P
art
ner
rece
ived a
n H
IV test
□
Part
ner
refu
sed a
n H
IV test
□
Part
ner
know
n to b
e H
IV-p
osi
tive
□ O
ther:
Part
ner’
s H
IV s
tatu
s (
if t
este
d):
□
HIV
-posi
tive
□ H
IV-n
egativ
e
Is t
he p
art
ner
on
AR
T (
if H
IV-p
osit
ive)?
□
Yes
□
No
/ /
PA
RT
NE
R 2
G
en
der:
□ M
ale
□ F
em
ale
□
Tra
nsg
ender
Date
of
bir
th:
Typ
e o
f p
art
ner
testi
ng
: □
Clie
nt □
Pro
vider
□ C
ontr
act, d
ate
_
D
ate
/Meth
od
of
1s
t co
nta
ct
att
em
pt:
/ /
P
hone
Hom
e
Date
/Meth
od
of
2n
d c
on
tact
att
em
pt:
/ /
P
hone
Hom
e
Date
/Meth
od
of
3rd
co
nta
ct
att
em
pt:
/ /
P
hone
Hom
e
Was
part
ner
co
nta
cte
d?
□
Yes
□
No
If y
es, w
ho
co
nta
cte
d p
art
ner?
□
Clie
nt □
Pro
vider
□ C
lient +
Pro
vider
Ou
tco
me o
f P
art
ne
r Testi
ng
Serv
ices:
□ P
art
ner
rece
ived a
n H
IV test
□
Part
ner
refu
sed a
n H
IV test
□
Part
ner
know
n to b
e H
IV-p
osi
tive
□ O
ther:
Part
ner’
s H
IV s
tatu
s (
if t
este
d):
□
HIV
-posi
tive
□ H
IV-n
egativ
e
Is t
he p
art
ner
on
AR
T (
if H
IV-p
osit
ive)?
□
Yes
□
No
/ /
PA
RT
NE
R 3
Ou
tco
me
of
Part
ner
Tes
tin
g S
erv
ice
s
Fo
rm
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 9 of 18
![Page 20: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/20.jpg)
IND
EX
CL
IEN
T IN
FO
RM
AT
ION
Nam
e:
HT
S/A
RT
Clin
ic N
um
ber:
Gen
der:
□
Male
□ F
em
ale
□ T
ransg
ender
D
ate
of
bir
th:
/ /
No
. o
f ch
ild
ren
:
Testi
ng
Ou
tco
me F
orm
fo
r H
IV-e
xp
osed
ch
ild
ren
N
am
e:
Gen
de
r:
□ M
ale
□
Fem
ale
Date
of
bir
th:
Ch
ild
’s H
IV s
tatu
s:
□ H
IV-p
osi
tive □
HIV
-negativ
e
□ U
nkn
ow
n
If t
este
d H
IV-p
osit
ive:
AR
T s
tart
da
te
/ /
AR
T C
lient N
um
ber
__
__
__
__
_
/ /
Ch
ild
1
Na
me:
Gen
de
r:
□ M
ale
□
Fem
ale
Date
of
bir
th:
Ch
ild
’s H
IV s
tatu
s:
□ H
IV-p
osi
tive □
HIV
-negativ
e
□ U
nkn
ow
n
If t
este
d H
IV-p
osit
ive:
AR
T s
tart
da
te
/ /
AR
T C
lient N
um
ber
_
_________
/ /
Ch
ild
1
Na
me:
Gen
de
r:
□ M
ale
□
Fem
ale
Date
of
bir
th:
Ch
ild
’s H
IV s
tatu
s:
□ H
IV-p
osi
tive □
HIV
-negativ
e
□ U
nkn
ow
n
If t
este
d H
IV-p
osit
ive:
AR
T s
tart
da
te
/ /
AR
T C
lient N
um
ber
_
_________
/ /
Ch
ild
1
Na
me:
Gen
de
r:
□ M
ale
□
Fem
ale
Date
of
bir
th:
Ch
ild
’s H
IV s
tatu
s:
□ H
IV-p
osi
tive □
HIV
-negativ
e
□ U
nkn
ow
n
If t
este
d H
IV-p
osit
ive:
AR
T s
tart
da
te
/ /
AR
T C
lient N
um
ber
__
__
__
__
_
/ /
Ch
ild
1
In
st
ns
ructi
o
• • • •
Com
ple
te t
his
test
ing f
orm
for
all
bio
logic
al c
hild
ren
of
the
ind
ex
clie
nt.
If
the
ind
ex
pa
tien
t h
as
mo
re t
ha
n f
ou
r ch
ildre
n,
com
ple
te a
dd
itio
na
l fo
rms
as
needed s
o t
hat
all
child
ren a
re r
eco
rde
d.
If the in
dex
HIV
patie
nt
is a
child
, co
mp
lete
th
e f
orm
fo
r a
ll th
e c
hild
's s
iblin
gs
an
d b
iolo
gic
al p
are
nts
.C
hild
ren o
f m
ale
index
clie
nts
do n
ot
ne
ed
HIV
te
stin
g,
un
less
th
eir b
iolo
gic
al m
oth
er
is H
IV-p
osi
tive
, d
ece
ase
d,
or
he
r H
IV s
tatu
s is
un
kno
wn
/no
tdocu
mente
d.
This
form
should
be r
evi
ew
ed a
nd u
pd
ate
d a
t le
ast
an
nu
ally
.
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 10 of 18
![Page 21: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/21.jpg)
ILLUSTRATION OF FOUR STREAMS OF CARE
PREVENTIVE /
PROMOTIVE
CARE STREAM
– MCWH
(by appointment)
Well adults and well
children
Maternal health
• Antenatal
• Post natal
Reproductive
health
• ToP
• Family
Planning
• Sterilisation
• MMC
Child health
• Well Baby Clinic
• Immunisation
SERVICES
(Allied health
services)
STREAM
(by appointment)
Oral Health
Physical Therapy
• Physiotherapist
• Occupational Therapist
Podiatry
Speech and
Hearing Therapy
Mental Health team
• Psychiatrist
• Psychologists
• Mental health
nurse
st 1 visit
support services
Eye Care
ACUTE / MINOR
AILMENTS
STREAM
(unplanned
visits)
Adults and children
daily visits
Episodic care
Minor ailment
Access to MC & SRH
st for the 1 time Conrmationof pregnancy
and family planning
Universal
test and treat (UTT)
Medical
emergency
Referral from
community screening
including index case
contact testing
CHRONIC
STREAM
(by appointment)
Adults and children
with known chronic
conditions
HIV • Pre-ART
• ART initiation
TB
NCDs
• Diabetes
• Hypertension
• Cardio vascular
• Asthma
• Epilepsy
• Other
Mental health
ST 1 visit chronic
conditions
• IPT
Drug-sensitive
• MDR down -
referral
•
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 11 of 18
![Page 22: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/22.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 12 of 18
Recep
tio
n
![Page 23: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/23.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 13 of 18
![Page 24: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/24.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 14 of 18
![Page 25: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/25.jpg)
Clinical algorithm to scale up TB Preventive
Therapy (TPT) for adolescents and adults (15+ years of age)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 15 of 18
![Page 26: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/26.jpg)
IPT Monitoring Process
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 16 of 18
![Page 27: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/27.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 17 of 18
![Page 28: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/28.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section B - page 18 of 18
![Page 29: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/29.jpg)
![Page 30: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/30.jpg)
• Know 90-90-90 Strategy and target-setting toolkit
• Individual must know HTS policy
• Know facility targets and COP targets
• Know performance of facility (DHIS)
• Agree on process
• Discuss tools for implementing and monitoring
(conrm HTS and pre-ART modules in use)
• Conduct skills audit >> training plan (including prociency testing
(PT) for all testers)
• Potential missed opportunities (from headcount)
• Review current workload of testers
• Review facility HTS Barometer
• Discuss PITC targets and target-setting
• Discuss SCM regarding HTS (test-kits and consumables)
• Discuss intra-facility and community data ow process
• Map current service points in facility
• Create current patient ow
• Map potential PITC patient ow
• Engage all stakeholders (including Clinic Committee and CBOs)
• Map new PITC process ow
• Orientate all testers on tools and processes,
and on daily reporting requirements
• Brief all facility team members, including security staff
• Inform Clinic Committee if not part of the new process activity
• Arrange signage
• Review appointment system
• Toolkit in each room
• Patient stationery
• Job aids
• Ensure a friendly environment for under-5s
• Ensure a youth-friendly environment
• For Operational Manager
• For facility testers (Nurse Clinicians and Lay Counsellors)
• For Data Capturers
• For Information Teams
Review PITC performance through:
• daily HTS Register review;
• daily individual performances against individual targets;
• weekly facility performance against facility target;
• bi-weekly review of dashboard data.
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 1 of 16
![Page 31: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/31.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 2 of 16
![Page 32: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/32.jpg)
• B
eco
me
fa
mili
ar
with
th
e P
ha
rma
cy N
CS
to
ol,
Ide
al C
linic
ass
ess
ment to
ol,
and L
ab a
ssess
ment to
ol.
• R
evi
ew
/sca
n th
e c
urr
en
t D
HP, D
IP/D
OP, F
aci
lity
Pro
le
, F
IP/F
OP, base
line r
eport
, F
aci
lity
QIP
and
D
QA
R
ep
ort
s, 1
0/1
0 to
ols
an
d r
ep
ort
s, P
HC
an
d P
rog
ram
me r
evi
ew
tools
and r
eport
s.•
Fa
cilit
ate
ide
nti
catio
n o
f a
nd
en
ga
ge
me
nt w
ith r
ele
van
t st
ake
hold
ers
. •
An
aly
se th
e c
olle
cte
d in
form
atio
n a
nd
co
mp
ile th
e r
ep
ort
and p
rese
nta
tion.
• D
en
e th
e in
ten
tion
of th
e b
ase
line
ass
ess
me
nt.
• A
gre
e o
n th
e d
ate
an
d tim
e fo
r a
sse
ssm
en
t.•
Ag
ree
on
th
e p
eo
ple
/te
am
invo
lve
d.
• C
om
ple
te a
ll to
ols
as
ab
ove
.•
Orie
nta
te th
e F
aci
lity
Tea
m o
n th
e to
ols
an
d p
roce
ss.
• R
evi
ew
oth
er
rep
ort
s (ite
ms
2.2
to
2.8
in th
e F
aci
lity
Ba
selin
e R
eport
tem
pla
te).
• C
on
du
ct th
e b
ase
line
ass
ess
me
nt.
• C
he
ck p
rog
ress
on
all
QIP
s a
nd
ide
ntif
y g
oo
d p
ract
ice
s a
nd g
aps
• G
ive
fe
ed
ba
ck o
n th
e b
ase
line
ass
ess
me
nt.
• D
eve
lop
th
e Q
IP b
ase
d o
n g
ap
s id
en
tie
d (
usi
ng
th
e B
ottle
ne
ck A
na
lysi
s te
mp
late
s).
• D
eve
lop
th
e Q
IP b
ase
d o
n g
ap
s id
en
tie
d (
usi
ng
th
e B
ottle
ne
ck A
na
lysi
s te
mp
late
s).
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 3 of 16
![Page 33: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/33.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 4 of 16
![Page 34: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/34.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 5 of 16
![Page 35: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/35.jpg)
PHC Area Manager mentors the OM
OM/CEOleads the
team
School Health representative
Ward-based Outreach Team representative
Ward AIDS Committee
Chairperson
Facility staff (both clinical
and data)
Clinic Committee / Hospital Board representative
Facility Technical
Working Group
Implementing Partner
representatives
Facility Technical Working Group (FTWG) stakeholders
Facility Planning Cycle
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 6 of 16
How do we know if we have arrived?
How do we get there?
Measure and evaluate
Where are we now?
Conduct baseline assessment of current performance
on all four pillars
Where are we going?
Setting of targets
Develop QIP with interventions
![Page 36: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/36.jpg)
Introduction
• Purpose of developing FIP• Steps for FIP development• Patient Management Cascades• Data needed to complete the FIP• The core participants are the facility staff (check the DIP).
SMART AIM
• Set out an aim statement for each cascade pillar• Identify priority population groups to focus your aim statement
Facility Implementation Plan (FIP) development process
Map stakeholders
• Map stakeholders for each of the cascade pillars• Include CBOs, LAC, WAC, PLWHIV, etc.
Review current situation
• Review performance data for each pillar using run-charts, performance dashboard and cascades• Review previous plan (reect on the activities implemented successfully)
Bottleneck and Root Cause Analysis
• Brainstorm bottlenecks and issues leading to poor performance for each cascade as seen in the 2X4 Matrix
• Prioritise three bottlenecks• Use the BNA guiding
questions or • Place these in the Fishbone• Apply '5 Whys’ to get to the
root causes (whether using the guiding questions or the Fishbone)
Design interventions
Brainstorm possible solutions to address the identied root causes from the bottleneck analysis:• Prioritise high-impact
activities using the Prioritisation Matrix
• Populate the FIP template • Review implementation of
the plan in 90 days and develop a QIP
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 7 of 16
![Page 37: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/37.jpg)
Introduce the 2x4 Matrix
Brainstorm bottlenecks for each cascade pillar
Prioritise 3 bottlenecks per cascade and place these on the Fishbone
Respond to the guiding questions for each prioritised bottleneck
Get to the root causes using the '5 Why’
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 8 of 16
![Page 38: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/38.jpg)
Do
cu
men
t H
IV r
esu
lts
• R
egis
trat
ion
Cle
rk:
Cap
ture
pat
ient
’s fu
ll ID
Num
ber
in H
PR
S a
nd p
atie
nt r
ecor
d du
ring
patie
nt r
egis
trat
ion
• P
N:
Writ
e ID
Num
ber
in H
TS
Reg
iste
r an
d cl
inic
al s
tatio
nery
as
the
uniq
ue id
entifi
er
• D
atC
ap:
Ent
er H
TS
res
ults
from
HT
S R
egis
ter
into
TIE
R.N
et H
TS
mod
ule
• D
atC
ap:
Ent
er c
lient
s in
itiat
ed o
n A
RT
resu
lts fr
om c
linic
al s
tatio
nery
into
TIE
R.N
et A
RT
mod
ule
• D
atC
ap:
Use
sea
rch
func
tion
(ID
; nam
e; d
ate
of b
irth;
fold
er n
umbe
r) in
to T
IER
.Net
to p
reve
nt d
uplic
ate
entr
ies
Iden
tify
H
IV+
no
t o
n
AR
T
• D
atC
ap:
Run
‘Wai
ting
for A
RT
List
’ rep
ort o
n cl
ient
s w
ho a
re H
IV-p
ositi
ve b
ut n
ot in
itiat
ed o
n A
RT
• D
atC
ap:
Run
‘HIV
Mis
sed
App
oint
men
ts /
uLT
F S
elec
tion’
rep
ort
on c
lient
s w
ho a
re H
IV-p
ositi
ve a
nd o
n
AR
T w
ho m
isse
d an
app
oint
men
t
• D
atC
ap:
Pro
vide
OM
with
list
of H
IV-p
ositi
ve p
atie
nts
not o
n A
RT
who
wer
e ne
ver
initi
ated
and
/or
m
isse
d ap
poin
tmen
ts
Tra
cin
g
an
d lin
kag
e
OM
: P
rovi
de L
inka
ge O
ffice
r/tr
acin
g te
am w
ith li
st o
f HIV
-pos
itive
pat
ient
s no
t on
AR
T w
ho w
ere
neve
r
ini
tiate
d an
d/or
mis
sed
appo
intm
ents
Lin
kag
e O
ffice
rs: T
race
HIV
-pos
itive
pat
ient
s no
t on
AR
T
PN
: In
itiat
e H
IV-p
ositi
ve p
atie
nt o
n A
RT
Pro
cess
ow
s f
or
un
iqu
e ID
an
d lin
kag
e m
on
ito
rin
g
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 9 of 16
![Page 39: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/39.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 10 of 16
![Page 40: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/40.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 11 of 16
![Page 41: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/41.jpg)
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 12 of 16
![Page 42: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/42.jpg)
Linkage Ofcer:(90-90-90):
mobilisation, tracing, retention in care
Community Mobiliser:Clinician support and
community mobilisation –st nd 1 and 2 90
FACILITY:Nurse Clinician and
Data Capturer
WBOTs:
Professional Nurse
Enrolled Nurse
Community caregivers
CBOs
Professional Nurse
Data Capturer
Administrators
Facilitatorsnd rd2 and 3 90
Active referrals
Community Dialogues
Health education
Tracking and tracing
Community events
TMC and MMC
Referrals toOutreach Teams
Traditional CouncilsWar Rooms
AIDS CouncilsWard AIDS Committees
Stakeholder engagement
and participation between
community and facility
LTFU and H
TC lists
Missed appointments
Referrals
Testi
ng and
scre
ening gaps
Referrals
Stable and adherent
Return to treatment
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 13 of 16
![Page 43: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/43.jpg)
Purpose:
Liaises between Nurse Clinician and Data Capturer at facility level to mobilise community through outreach teams, links with CBOs and delivery of services into the community
Role:
1. Community engagement through stakeholder structures: � Ward AIDS Committee � War Rooms � CBOs � Traditional Councils
2. Support the 90-90-90 Strategy3. Link clients to facility for care and treatment4. Index case contact testing and tracing5. Health Education
Tools used:
Referral forms
Track and Trace tool
Early/Late Missed Appointment Register
Guidance for LTFU engagement
LTFU lists
Index case contact tracing tools
Data–client file and TIER.Net
Flipchart tools
HTC Registers
CBO community mobilisation schedules
Adherence Club schedule
Support Group schedule
Co-infected Client Case ID Register
Data ow
Facility:
Client data held by community ‒ TIER.Net, patient les, Early / Late /
Missed Appointment Registers and LTFU Lists
Nurse ClinicianFacility Data Capturer
Linkage Ofcer: Stakeholder engagement
Civil society / CBOsWard AIDS CommitteesWBOTsOperation Sukuma Sakhe
Client referral /data returned for capture
Household assessmentsCommunity testing/initiationHealth EducationDecanting: Adherence clubs CCMDD external pick-up points Spaced Fast-laneSupport groups
Community members provided with services:Community stakeholders:
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 14 of 16
![Page 44: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/44.jpg)
Patients attend the club every two months
Patient details are entered into the Adherence Club Register at attendance of the meeting
CBO Club Facilitator completes the tally sheet using the Adherence Club Register
CBO Data Capturer extracts data from the Adherence Club
Register and reports to DME by stthe 1 of each month
CBO Club Facilitator submits the Adherence Club Register to the
Facility Manager for capturing within 5 days of club meeting
1. Facility Manager receives the Register2. Facility Manager signs off the tally sheet3. Facility Manager gives the facility Data Capturer the Adherence Club Register for capturing in TIER.Net
1. Facility Data Capturer captures the data from the Adherence Club Register into TIER.Net system within 2 days2. Facility Data Capturer hands the Adherence Club Register to the Facility Manager
CBO Club Facilitator fetches the Adherence Club Register from the facility for the next
adherence club meeting
CBO Manager updates facility calendar with club dates
CBO Facilitator noties the HST Nurse Clinician of blood dates 2 months in advance
CCMDD TA checks the manifests returned
HST Data Capturer ensures that the process is completed and data are captured
HST Data Nurse Clinician reviews Adherence Club Registers for accuracy against client le notes, and refers errors
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 15 of 16
![Page 45: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/45.jpg)
TIER.Net (key focus)Reporting and utilising
information for decision-making
Data quality assurance
• Signed off, no backlogs, and maintenance
• HTS Module implementation with all HTS results captured
• ART Module: All required results entered from clinical stationery daily
• Capture ID numbers daily as unique identication in the absence of folder number; correct name, date of birth or physical address to prevent duplication
• ART clients decanted to CCMDD and adherence clubs are correctly captured in TIER.Net daily
• IPT start- and end-dates and outcomes correctly captured daily
• VL and CD4 results entered into and
• Generate Early Warning Indicators (EWI), 90-90-90 Tracer Indicators and QIP Indicators to monitor the HIV programme effectiveness at facility level: bi-weekly, monthly and quarterly
• Generate TIER.Net reports to trace and link clients to care weekly and monthly
• DATIM and DIMES: report monthly results; ensure that results reported match results in source documents
• DsD results: collect and report weekly
• Verify data daily• Weekly Registers / clinical
stationery review• Conduct TIER.Net audit
monthly
Supervision of Data Capturers SOP
HIV and TB Supportive Supervision Toolkit (version November 2018) Section C - page 16 of 16
![Page 46: (version November 2018) · SOP TB TIER.Net TMC TPT ToP QI QIP uLTF VL WAC WBOT WPHCOT 10/10 maternal, child and women's health monitoring and evaluation multidrug-resistant medical](https://reader033.vdocuments.mx/reader033/viewer/2022041519/5e2d6682e33e7a4c40491097/html5/thumbnails/46.jpg)
For more information, contact one of our offices:
Durban (Head Office): 34 Essex Terrace, Westville, 3630
Tel: +27 (0)31 266 9090
Johannesburg: 1st Floor, Block J, Central Park,
400 16th Road, Midrand, 1682Tel: +27 (0)11 312 4524
Cape Town: Block B, Aintree Office Park, Doncaster Road,
Kenilworth, 7700 Tel: +27 (0)21 762 0700
Email: [email protected]: 086 588 0394
Web: http://www.hst.org.za